Zyversa Therapeutics, Inc. (ZVSA) — S-1/A Filings
All S-1/A filings from Zyversa Therapeutics, Inc.. Browse 2 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (2)
-
ZyVersa Files S-1/A for Continuous Offering, Eyes Capital Infusion
— Aug 1, 2025 Risk: medium
ZyVersa Therapeutics, Inc. filed an S-1/A on August 1, 2025, as Amendment No. 2 to its Form S-1 Registration Statement (Registration No. 333-288470) for a delay -
ZyVersa Amends S-1, Signals Continuous Offering Strategy
— Jul 18, 2025 Risk: high
ZyVersa Therapeutics, Inc. filed an S-1/A on July 18, 2025, for a delayed or continuous offering of securities, indicating a strategic move to secure capital. T
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX